BioCatalyst

ALMS — ALUMIS INC. catalysts

1 verified catalyst event(s) for ALUMIS INC. (ticker ALMS). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-07-01 — Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Sy · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07-01
in 9d
ESTIMATED
 READOUT
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in
Phase 2 · SLE
 ALMS ALUMIS INC. Envudeucitinib ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.